Related Experiment Video
Updated: Jul 11, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review
Derek Yung1, Dan Kottachchi, Binod Neupane
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Background:
Right-sided endocarditis (RSE) is a serious complication of intravenous drug use. We sought to systematically review the evidence for obtaining clinical cure with antimicrobials in intravenous drug users (IVDUs) with isolated native valve RSE.
Search Strategy:
We applied broad search strategies in the following databases: MEDLINE (1966-2006), EMBASE (1980-2006) and Cochrane CENTRAL Register (2006, Issue 3). Hand searching was performed on selected peer-reviewed journals and relevant citation lists were screened. No restrictions were set on language and type of publication.
Selection Criteria:
We included randomized controlled trials that evaluated clinical and microbiological cure using single or combination antibiotic regimens for the treatment of isolated native valve bacterial RSE. Clinical and microbiological cure and failure outcomes were evaluated between 2 weeks and 6 months after completion of therapy. Quality assessment of relevant studies was performed using an objective scoring scale.
Results:
We identified seven randomized controlled trials, one comparing single antimicrobial therapies, four comparing combination with single therapy and two studies comparing combination therapies. Short-course therapy was present in at least one arm in three studies, but only one study compared short- and long-course therapy. No statistically significant benefit was demonstrated between any antimicrobial therapy and all studies were scored as having a moderate to severe risk of bias.
Conclusions:
Randomized trial evidence does not support one antimicrobial regimen over another in the treatment of RSE in IVDUs.
Insights
This systematic review found no evidence that one antimicrobial regimen is superior to another for treating right-sided endocarditis (RSE) in intravenous drug users (IVDUs). Further research is needed to determine optimal treatment strategies for RSE in this population.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Right-sided endocarditis (RSE) is a significant complication associated with intravenous drug use (IVDU).
- Evidence regarding antimicrobial efficacy for clinical cure in IVDUs with isolated native valve RSE requires systematic evaluation.
Purpose of the Study:
- To systematically review randomized controlled trials (RCTs) evaluating antimicrobial regimens for clinical cure in IVDUs with isolated native valve RSE.
Main Methods:
- Searched MEDLINE, EMBASE, and Cochrane CENTRAL Register (1966-2006).
- Included RCTs comparing single or combination antibiotic regimens for isolated native valve bacterial RSE.
- Assessed clinical and microbiological cure and failure outcomes between 2 weeks and 6 months post-therapy.
- Evaluated study quality using an objective scoring scale.
Main Results:
- Identified seven RCTs: one single vs. single, four combination vs. single, and two combination vs. combination.
- Short-course therapy was evaluated in three studies, with only one directly comparing short- and long-course therapy.
- No statistically significant benefit was found for any antimicrobial therapy.
- All included studies exhibited a moderate to severe risk of bias.
Conclusions:
- Current randomized trial evidence does not support the superiority of any specific antimicrobial regimen for treating RSE in IVDUs.
- The lack of clear evidence highlights the need for further high-quality research to guide treatment decisions.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
